rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christine Siu

Director

Company insider

Files Form 4 as: Director, Monte Rosa Therapeutics; CFO and Secretary, Eidos Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
48
Buys
0
Sells
9
Bought
$0
Sold
$4.8M
Companies
2
Companies where not an officer
1
First trade
5 Nov 2018
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
Eidos TherapeuticsOfficer · last 9 Dec 20190 buys · 9 sells
Everywhere else they filed: board seats, 10% stakes, other companies
GLUE Monte Rosa TherapeuticsDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,800 at $0.00filing
11 Jun 2026filed 12 Jun 2026GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,800 at $0.00filing
13 Jun 2025filed 16 Jun 2025GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,700 at $0.00filing
12 Jun 2024filed 13 Jun 2024GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,100 at $0.00filing
14 Jun 2023filed 15 Jun 2023GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,500 at $0.00filing
15 Jun 2022filed 16 Jun 2022GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
23 Jun 2021filed 25 Jun 2021GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—47,132 at $0.00filing
12 Apr 2021filed 25 Jun 2021GLUE Monte Rosa Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,081 at $0.00filing
9 Dec 2019filed 11 Dec 2019Eidos Therapeuticsoption or derivativeSEC FORM 4 Code M—10,000 at $0.00filing
9 Dec 2019filed 11 Dec 2019Eidos TherapeuticsSEC FORM 4 Code M$5,90010,000 at $0.59filing
9 Dec 2019filed 11 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$542K9,099 at $59.62filing
9 Dec 2019filed 11 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$54K901 at $60.05filing
4 Dec 2019filed 5 Dec 2019Eidos Therapeuticsoption or derivativeSEC FORM 4 Code M—10,000 at $0.00filing
4 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Code M$5,90010,000 at $0.59filing
4 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$516K8,800 at $58.60filing
4 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$71K1,200 at $59.39filing
3 Dec 2019filed 5 Dec 2019Eidos Therapeuticsoption or derivativeSEC FORM 4 Code M—10,000 at $0.00filing
3 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Code M$5,90010,000 at $0.59filing
3 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$35K600 at $57.82filing
3 Dec 2019filed 5 Dec 2019Eidos TherapeuticsSEC FORM 4 Sold$318K5,400 at $58.95filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.